Advertisements
Upcoming events at this venue
2nd Peptide-Based Therapeutics Summit
#_EVENTSTARTDATE
01 Apr - 03 Apr 2025, 8:00 am - 5:00 pm
With Merck's oral PCSK9 inhibitor demonstrating strong phase 3 trial results, J AND J's IL23R antagonist peptide...